Document:

<PAGE>

                                                                    EXHIBIT 10.4

                            CARDIOGENESIS CORPORATION
                          EMPLOYEE STOCK PURCHASE PLAN

                             (AS AMENDED, JULY 2005)

     The following constitute the provisions of the 1996 Employee Stock Purchase
Plan of Cardiogenesis Corporation (formerly Eclipse Surgical Technologies, Inc.)

1. Purpose. The purpose of the Plan is to provide employees of the Company and
its Designated Subsidiaries with an opportunity to purchase Common Stock of the
Company through accumulated payroll deductions. It is the intention of the
Company to have the Plan qualify as an "Employee Stock Purchase Plan" under
Section 423 of the Internal Revenue Code of 1986, as amended. The provisions of
the Plan, accordingly, shall be construed so as to extend and limit
participation in a manner consistent with the requirements of that section of
the Code.

2. Definitions.

     (a) "Board" shall mean the Board of Directors of the Company.

     (b) "Code" shall mean the Internal Revenue Code of 1986, as amended.

     (c) "Common Stock" shall mean the Common Stock of the Company.

     (d) "Company" shall mean Cardiogenesis Corporation (formerly Eclipse
Surgical Technologies, Inc.) and any Designated Subsidiary of the Company.

     (e) "Compensation" shall mean all base straight time gross earnings,
commissions, overtime, shift premium, incentive compensation, incentive
payments, bonuses and other compensation.

     (f) "Designated Subsidiaries" shall mean the Subsidiaries which have been
designated by the Board from. time to time in its sole discretion as eligible to
participate in, the Plan.

     (g) "Employee" shall mean any individual who is an Employee of the Company
for tax purposes whose customary employment with the Company is at least twenty
(20) hours per week and more than five (5) months in any calendar year. For
purposes of the Plan, the employment relationship shall be treated as continuing
intact while the individual is on sick leave or other leave of absence approved
by the Company. Where the period of leave exceeds 90 days and the individual's
right to reemployment is not guaranteed either by statute or by contract, the
employment relationship shall be deemed to have terminated on the 91st day of
such leave.

     (h) "Enrollment Date" shall mean the first day of each Offering Period.

     (i) "Exercise Date" shall mean the last day of each Offering Period.

     (j) "Fair Market Value" shall mean, as of any date, the value of Common
Stock determined as follows:

          (1) If the Common Stock is listed on any established stock exchange or
a national market system, including without limitation the Nasdaq National
Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market
Value shall be the closing sales price for such stock (or the closing bid, if no
sales were reported) as quoted on such exchange or system for the last market
trading day prior to the time of determination, as reported in The Wall Street
Journal or such other source as the Administrator deems reliable, or;

          (2) If the Common Stock is regularly quoted by a recognized securities
dealer but selling prices are not reported, its Fair Market Value shall be the
mean of the closing bid and asked prices for the Common Stock on the date of
such determination, as reported in The Wall Street Journal or such other source
as the Board deems reliable, or;

<PAGE>

          (3) In the absence of an established market for the Common Stock, the
Fair Market Value thereof shall be determined in good faith by the Board.

          (4) For the purposes of the Enrollment Date under the first Offering
Period under the Plan, the Fair Market Value of the Common Stock shall be the
price to public as set forth in the final prospectus included within the
Registration Statement on Form S-1 filed with the Securities and Exchange
Commission for the initial public offering the Common Stock.

     (k) "Offering Period" shall mean a period of approximately six (6) months,
commencing on the first Trading Day on or after May 16 and terminating on the
last Trading Day in the period ending the following November 15, or commencing
on the first Trading Day on or after November 16 and terminating on the last
Trading Day in the period ending the following May 15, during which an option
granted pursuant to the Plan may be exercised; provided, however, that the first
Offering Period shall be the period of approximately seven (7) months,
commencing with the first Trading Day on or after the date on which the
Company's Registration Statement on Form S-1 is declared effective by the
Securities and Exchange Commission and terminated on the last Trading Day in the
period ending November 15. The duration of Offering Periods. may be changed
pursuant to Section 4 of this Plan.

     (l) "Plan" shall mean this Employee Stock Purchase Plan.

     (m) "Purchase Price" shall mean an amount equal to 85% of the Fair Market
Value of a share of Common Stock on the Enrollment Date or on the Exercise Date,
whichever is lower.

     (n) "Reserves" shall mean the number of shares of Common Stock covered by
each option under the Plan which have not yet been exercised and the number of
shares of Common Stock which have been authorized for issuance under the Plan
but not yet placed under option.

     (o) "Subsidiary" shall mean a corporation, domestic or foreign, of which
not less than 50% of the voting Shares are held by the Company or a Subsidiary
whether or not such corporation now exists or is hereafter organized or acquired
by the Company or a Subsidiary.

     (p) "Trading Day" shall mean a day on which national stock exchanges and
the Nasdaq System are open for trading.

3. Eligibility.

     (a) Any Employee (as defined in Section 2(g)), who shall be employed by the
Company on a given Enrollment Date shall be eligible to participate in the Plan.

     (b) Any provisions of the Plan to the contrary notwithstanding, no Employee
shall be granted an option under the Plan (i) to the extent that, immediately
after the grant, such Employee (or any other person whose stock would be
attributed to such Employee pursuant to Section 424(d) of the Code) would own
capital stock of the Company and/or hold outstanding options to purchase such
stock possessing five percent (5%) or more of the total combined voting power or
value of all classes of the capital stock of the Company or of any Subsidiary,
or (ii) to the went that his or her rights to purchase stock under all employee
stock purchase plans of the Company and its subsidiaries accrues at a rate which
exceeds Twenty-Five Thousand Dollars ($25,000) worth of stock (determined at the
fair market value of the shares at the time such option is granted) for each
calendar year in which such option is outstanding at any time.

4. Offering Periods. The Plan shall be implemented by consecutive Offering
Periods with a new Offering Period commencing on the first Trading Day on or
after May 16 and November 16 each year, or on such other date as the Board shall
determine, and continuing thereafter until terminated in accordance with Section
19 hereof; provided, however, that the first Offering Period shall be the period
of approximately seven (7) months, commencing with the first Trading Day on or
after the date on which the Company's registration statement on Form S-1 is
declared effective by the Securities and Exchange Commission and terminating on
the last Trading Day in the Period ending November 15. The Board shall have the
power to change the duration of Offering Periods (including

                                        2

<PAGE>

the commencement dates thereof) with respect to future offerings without
shareholder approval if such change is announced at least five (5) days prior to
the scheduled beginning of the first Offering Period to be affected thereafter.

5. Participation.

     (a) An eligible Employee may become a participant in the Plan by completing
a subscription agreement authorizing payroll deductions in the form of Exhibit A
to this Plan and filing it with the Company's payroll office prior to the
applicable Enrollment Date.

     (b) Payroll deductions for a participant shall commence on the first
payroll following the Enrollment Date and shall end on the last payroll in the
Offering Period to which such authorization is applicable, unless sooner
terminated by the participant as provided in Section 10 hereof.

6. Payroll Deductions.

     (a) At the time a participant files his or her subscription agreement, he
or she shall elect to have payroll deductions made on each pay day during the
Offering Period in an amount not exceeding fifteen percent (15%) of the
Compensation which he or she receives on each pay day during the Offering
Period; provided, however, that with respect to the first Offering Period under
the Plan a participant may elect to deduct an amount not to exceed twenty
percent (20%) of the Compensation such participant receives on each pay day
during the first Offering Period.

     (b) All payroll deductions made for a participant shall be credited to his
or her account under the Plan and shall be withheld in whole percentages only. A
participant may not make any additional payments in to such account.

     (c) A participant may discontinue his or her participation in the Plan as
provided in Section 10 hereof, or may increase or decrease the rate of his or
her payroll deductions during the Offering Period by completing or filing with
the Company a new subscription agreement authorizing a change in payroll
deduction rate. The Board may, in its discretion, limit the number of
participation rate changes during any Offering Period. The change in rate shall
be effective with the first full payroll period following five (5) business days
after the Company's receipt of the new subscription agreement unless the Company
elects to process a given change in participation more quickly. A participant's
subscription agreement shall remain in effect for successive Offering Periods
unless terminated as provided in Section 10 hereof.

     (d) Notwithstanding the foregoing to the extent necessary to comply with
Section 423(b)(8) of the Code and Section 3(b) hereof, a participant's payroll
deductions may be decreased to zero percent (0%) at such time during any
Offering Period which is scheduled to end ,during the current calendar year (the
"Current Offering Period") that the aggregate of all payroll deductions which
were previously used to purchase stock under the Plan in a prior Offering Period
which ended during that calendar year plus all payroll deductions accumulated
with respect to the Current Offering Period equal $21,250. Payroll deductions
shall recommence at the rate provided in such participant's subscription
agreement at the beginning of the first Offering Period which is scheduled to
end in the following calendar year, unless terminated by the participant as
provided in Section 10 hereof.

     (e) At the time the option is exercised, in whole or in part, or at the
time some or all of the Company's Common Stock issued under the Plan is disposed
of, the participant must make adequate provision for the Company's federal.
state, or other tax withholding obligations, if any, which arise upon the
exercise of the option or the disposition of the Common Stock. At any time, the
Company may, but shall not be obligated to, withhold from the participant's
compensation the amount necessary for the Company to meet applicable withholding
obligations, including any withholding required to make available to the Company
any tax deductions or benefits attributable to sale or early disposition of
Common Stock by the Employee.

7. Grant of Option. On the Enrollment Date of each Offering Period, each
eligible Employee participating in such Offering Period shall be granted an
option to purchase on the Exercise Date of such Offering Period (at the
applicable Purchase Price) up to a number of shares of the Company's Common
Stock determined by dividing such

                                        3

<PAGE>

Employee's payroll deductions accumulated prior to such Exercise Date and
retained in the Participant's account as of the Exercise Date by the applicable
Purchase Price; provided that in no event shall an Employee be permitted to
purchase during each Offering Period more than a number of shares determined by
dividing $12,500 by the Fair Market Value of a share of the Company's Common
Stock on the Enrollment Date, and provided further that such purchase shall be
subject to the limitations set forth in Sections 3(b) and 12 hereof.
Notwithstanding anything to the contrary in this paragraph, with respect to the
first Offering Period under the Plan, an Employee shall not be permitted to
purchase more than the number of shares determined by dividing $25,000 by the
Fair Market Value of a share of the Company's Common Stock on the Enrollment
Date, except that such purchase shall be subject to the limitations set forth in
Sections 3(b) and 12 hereof Exercise of the option shall occur as provided in
Section 8 hereof, unless the participant has withdrawn pursuant to Section 10
hereof. The Option shall expire on the last day of the Offering Period.

8. Exercise of Option. Unless a participant withdraws from the Plan as provided
in Section 10 hereof his or her option for the purchase of shares shall be
exercised automatically on the Exercise Date, and the maximum number of full
shares subject to option shall be purchased for such participant at the
applicable Purchase Price with the accumulated payroll deductions in his or her
account. No fractional shares shall be purchased; any payroll deductions
accumulated in a participant's account which are not sufficient to purchase a
full share shall be retained in the participant's account for the subsequent
Offering Period, subject to earlier withdrawal by the participant as provided in
Section 10 hereof My other monies left over in a participant's account after the
Exercise Date shall be returned to the participant. During a participant's
lifetime, a participant's option to purchase shares hereunder is exercisable
only by him or her.

9. Delivery. As promptly as practicable after each Exercise Date on which a
purchase of shares occurs, the Company shall arrange the delivery to each
participant, as appropriate, of a Certificate representing the shares purchased
upon exercise of his or her option.

10. Withdrawal; Termination of Employment.

     (a) A participant may withdraw all but not less than all the payroll
deductions credited to his or her account and not yet used to exercise his or
her option under the Plan at any time by giving written notice to the Company in
the form of Exhibit B to this Plan. All of the participant's payroll deductions
credited to his or her account shall be paid to such participant promptly after
receipt of notice of withdrawal and such participant's option for the Offering
Period shall be automatically terminated, and no further payroll deductions for
the purchase of shares shall be made for such Offering Period. If a participant
withdraws from an Offering Period, payroll deductions shall not resume at the
beginning of the succeeding Offering Period unless the participant delivers to
the Company a new subscription agreement.

     (b) Upon a participant's ceasing to be an Employee (as defined in Section
2(g) hereof) for any reason, he or she shall be deemed to have elected to
withdraw from the Plan and the payroll deductions credited to such participant's
account during the Offering Period but not yet used to exercise the option shall
be returned to such participant or, in the case of his or her death, to the
person or persons entitled thereto under Section 14 hereof, and such
participant's option shall be automatically terminated. The preceding sentence
notwithstanding, a participant who receives payment in lieu of notice of
termination of employment shall be treated as continuing to be an Employee for
the participant's customary number of hours per week of employment during the
period in which the participant is subject to such payment in lieu of notice.

     (c) A participant's withdrawal from an Offering Period shall not have any
effect upon his or her eligibility to participate in any similar plan which may
hereafter be adopted by the Company or in succeeding Offering Periods which
commence after the termination of the Offering Period from which the participant
withdraws.

11. Interest. No interest shall accrue on the payroll deductions of a
participant in the Plan.

12. Stock.

     (a) The maximum number of shares of the Company's Common Stock which shall
be made available for sale under the Plan shall be 1,500,000 shares, subject to
adjustment upon changes in capitalization of the Company

                                        4

<PAGE>

as provided in Section 18 hereof. If, on a given Exercise Date, the number of
shares with respect to which options are to be exercised exceeds the lesser of
(i) 62,500 shares or (ii) the number of shares then available under the Plan,
the Company shall make a pro rata allocation of the shares up to the lesser of
(i) or (ii) in as uniform a manner as shall be practicable and as it shall
determine to be equitable.

     (b) The participant shall have no interest or voting right in shares
covered by his option until such option has been exercised.

     (c) Shares to be delivered to a participant under the Plan shall be
registered in the name of the participant or in the name of the participant and
his or her spouse.

13. Administration.

     (a) Administrative Body. The Plan shall be administered by the Board or a
committee of members of the Board appointed by the Board. The Board or its
committee shall have full arid exclusive discretionary authority to construe,
interpret and apply the terms of the Plan, to determine eligibility and to
adjudicate all disputed claims filed under the Plan. Every finding, decision and
determination made by the Board or its committee shall, to the full extent
permitted by law, be final and binding upon all parties.

     (b) Rule 16b-3 Limitations. Notwithstanding the provisions of Subsection
(a) of this Section 13, in the event that Rule 16b-3 promulgated under the
Securities Exchange Act of 1034, as amended (the "Exchange Act"), or any
successor provision ("Rule 16b-3") provides specific requirements for the
administrators of plans of this type, the Plan shall be administered only by
such a body and in such a manner as shall comply with the applicable
requirements of Rule 16b-3. Unless permitted by Rule 16b-3, no discretion
concerning decisions regarding the Plan shall be afforded to any committee or
person that is not "disinterested" as that term is used in Rule 16b-3.

14. Designation of Beneficiary.

     (a) A participant may file a written designation of a beneficiary who is to
receive any shares and cash, if any, from the participant's account under the
Plan in the event of such participant's death subsequent to an Exercise Date on
which the option is exercised but prior to delivery to such participant of such
shares and cash. In addition, a participant may file a written designation of a
beneficiary who is to receive any cash from the participant's account under the
Plan in the event of such participant's death prior to exercise of the option.
If a participant is married and the designated beneficiary is not the spouse,
spousal consent shall be required for such designation to be effective.

     (b) Such designation of beneficiary may be changed by the participant at
any time by written notice. In the event of the death of a participant and in
the absence of a beneficiary validly designated under the Plan who is living at
the time of such participant's death, the Company shall deliver such shares
and/or cash to the executor or administrator of the estate of the participant,
or if no such executor or administrator has been appointed (to the knowledge of
the Company), the Company, in its discretion, may deliver such shares and/or
cash to the spouse or to any one or more dependents or relatives of the
participant, or if no spouse, dependent or relative is known to the Company,
then to such other person as the Company may designate.

15. Transferability. Neither payroll deductions credited to a participants
account nor arty rights with regard to the exercise of an option or to receive
shares under the Plan may be assigned, transferred, pledged or otherwise
disposed of in any way (other than by will, the laws of descent and distribution
or as provided in Section 14 hereof) by the participant. Any such attempt at
assignment, transfer, pledge or other disposition shall be without effect,
except that the Company may treat such act as an election to withdraw funds from
an Offering Period in accordance with Section 10 hereof.

16. Use of Funds. All payroll deductions received or held by the Company under
the Plan may be used by the Company for any corporate purpose, and the Company
shall not be obligated to segregate such payroll deductions.

17. Reports. Individual accounts shall be maintained for each participant in the
Plan. Statements of account shall be given to participating Employees at least
annually, which statements shall set forth the amounts of payroll deductions,
the Purchase Price, the number of shares purchased and the remaining cash
balance, if any.

                                        5

<PAGE>

18. Adjustments Upon Changes in Capitalization, Dissolution, Liquidation, Merger
or Asset Sale.

     (a) Changes in Capitalization. Subject to any required action by the
shareholders of the Company, the Reserves, as well as the price per share and
the number of shares of Common Stock covered by each option under the Plan which
has not yet been exercised, shall be proportionately adjusted for any increase
or decrease in the number of issued shares of Common Stock resulting from a
stock split, reverse stock split, stock dividend, combination or
reclassification of the Common Stock, or any other increase or decrease in the
number of shares of Common Stock effected without receipt of consideration by
the Company; provided, however, that conversion of any convertible securities of
the Company shall not be deemed to have been "effected without receipt of
consideration". Such adjustment shall be made by the Board, whose determination
in that respect shall be final, binding and conclusive. Except as expressly
provided herein, no issuance by the Company of shares of stock of any class, or
securities convertible into shares of stock of any class, shall affect, and no
adjustment by reason thereof shall be made with respect to, the number or price
of shares of Common Stock subject to an option.

     (b) Dissolution or Liquidation. In the event of the proposed dissolution or
liquidation of the Company, the Offering Period shall terminate immediately
prior to the consummation of such proposed action, unless otherwise provided by
the Board.

     (c) Merger or Asset Sale. In the event of a proposed sale of all or
substantially all of the assets of the Company, or the merger of the Company
with or into another corporation, the Offering Period then in progress shall be
shortened by setting a new Exercise Date (the "New Exercise Date"). The New
Exercise Date shall be before the date of the Company's proposed sale or merger.
The Board shall notify each participant in writing, at least ten (10) business
days prior to the New Exercise Date, that the Exercise Date for the
participant's option has been changed to the New Exercise Date and that the
participant's option shall be exercised automatically on the New Exercise Date,
unless prior to such date the participant has withdrawn from the Offering Period
as provided in Section 10 hereof.

19. Amendment or Termination.

     (a) The Board of Directors of the Company may at any time and for any
reason terminate or amend the Plan. Except as provided in Section 18 hereof no
such termination can affect options previously granted, provided that an
Offering Period may be terminated by the Board of Directors on any Exercise Date
if the Board determines that the termination of the Plan is in the best
interests of the Company and its shareholders, except as provided in Section 18
hereof, no amendment may make any change in any option theretofore granted which
adversely affects the rights of any participant. To the extent necessary to
comply with Rule 16b-3 or under Section 423) of the Code (or any successor rule
or provision or any other applicable law or regulation), the Company shall
obtain shareholder approval in such a manner and to such a degree as required.

     (b) Without shareholder consent and without regard to whether any
participant rights may be considered to have been "adversely affected," the
Board (or its committee) shall be entitled to change the Offering Periods, limit
the frequency and/or number of changes in the amount withheld during an Offering
Period, establish the exchange ratio applicable to amounts withheld in a
currency other than U.S. dollars, permit payroll withholding in excess of the
amount designated by a participant in order to adjust for delays or mistakes in
the Company's processing of properly completed withholding elections, establish
reasonable waiting and adjustment periods and/or accounting and crediting
procedures to ensure that amounts applied toward the purchase of Common Stock
for each participant properly correspond with amounts withheld from the
participant's Compensation, and establish such other limitations or procedures
as the Board (or its committee) determines in its sole discretion advisable
which are consistent with the Plan.

20. Notice. All notices or other communications by a participant to the Company
under or in connection with the Plan shall be deemed to have been duly given
when received in the form specified by the Company at the location, or by the
person, designated by the Company for the receipt thereof.

21. Conditions Upon Issuance of Shares. Shares shall not be issued with respect
to an option unless the exercise of such option and the issuance and delivery of
such shares pursuant thereto shall comply with all applicable provisions of law,
domestic or foreign, including, without limitation, the Securities Act of 1933,
as amended, the Securities Exchange Act of 1934, as amended, the rules and
regulations promulgated thereunder, and

                                        6

<PAGE>

the requirements off any stock exchange upon which the shares may then be
listed, and shall be further subject to the approval of counsel for the Company
with respect to such compliance.

As a condition to the exercise of an option, the Company may require the person
exercising such option to represent and warrant at the time of any such exercise
that the shares are being purchased only for investment and without any present
intention to sell or distribute such shares if, in the opinion of counsel for
the Company, such a representation is required by any of the aforementioned
applicable provisions of law.

22. Term of Plan. The Plan shall become effective upon the earlier to occur of
its adoption by the Board of Directors or its approval by the shareholders of
the Company. It shall continue in effect until March 31, 2015 unless sooner
terminated under Section 19 hereof.

                                        7<PAGE>
                                                                   Exhibit 10.19

                              [CARDIOGENESIS LOGO]

                    CONFIDENTIALITY AND INTELLECTUAL PROPERTY
                                    AGREEMENT

     Cardiogenesis (the "Company") is dedicated to a policy of exerting a
significant influence in its chosen fields through technical innovation and
creative administration and marketing. The competitive success of this policy
depends to a large extent on the Company's ability to capitalize on the creative
talents of its employees and to maintain a free flow of pertinent information
among its employees.

     For this reason, all employees are requested to sign the following
Agreement under which:

     (I)  Requirements are specified for avoiding conflicting outside activities
          while the employee is associated with the Company as an employee,

     (II) The Company is assured of disclosure of an exclusive rights to ideas,
          works and inventions which relate to Company business,

     (III) The Company is protected against unauthorized disclosure of
          confidential information of the Company or other persons and against
          post-employment retention of Company records,

     (IV) Former Company employees are prohibited from soliciting other Company
          employees for one year,

     (V)  The Company's policy of "at will" employment is confirmed and a
          mechanism is established for resolution of any disputes between the
          Company and an employee.

<PAGE>

                                    AGREEMENT

In part consideration of my employment or continued employment by Cardiogenesis,
a California corporation, or by any of its affiliates (hereinafter collectively
referred to as the "Company"), and effective as of the date that said employment
first commenced, I agree that:

I.   Time Commitment and Conflict of Interest

     A.   Time Commitment

     During the term of my employment, in order to help ensure that I devote
most of my professional energies to the Company, I will not, without the prior
written approval of the President of the Company, engage in any other
professional employment or consulting.

     B.   Conflict of Interest

     During the term of my employment, I will not, without the prior written
approval of the President of the Company, directly or indirectly participate in
or assist any business which is a current or potential supplier, customer, or
competitor of the Company, except that I may invest to an extent not exceeding
one percent of the total outstanding shares in each of one or m ore companies
whose shares are listed on a national securities exchange or quoted daily by
NASDAQ.

     I represent that my performance of all the terms of this Agreement and my
work for the Company does not and will not breach any invention assignment or
proprietary information agreement with any former employer or other party or
create any conflict of interest with anyone. I agree that I will not disclose to
the Company or use for the benefit of the Company any confidential information
derived from sources other than employment with the Company. In these regards, I
will use in the performance of my duties only information which is generally
known and used by persons with training and experience comparable to my own,
which is common knowledge in the industry or otherwise legally in the public
domain, or which is otherwise provided or developed by the Company. I agree that
if I am in doubt as to the confidential status of any information, or if any
information is alleged to be proprietary, I will refer to the management of the
Company the question of whether such information is available for disclosure and
use for the benefit of the Company.

     I will not enter into any agreement with any other person or entity, either
written or oral, in conflict with the terms of this Agreement.

II.  Disclosure and Assignment to Company of Inventions

     A.   Disclosure to Company of Inventions

     Except as provided in the next sentence, I will disclose in confidence
promptly to the Company any ideas, inventions, works of authorship (including
but not limited to computer programs, software, logic design, and
documentation), improvements, or discoveries, whether or not paten table or
copyrightable ("Work Product"), which during the term of my employment, whether
or not in the course

                                       2
<PAGE>

of my employment, I may conceive, make, develop, work on, or first reduce to
practice, in whole or in part, either solely or jointly with others, whether or
not reduced to drawings, written description, documentation, models, or other
tangible form. The disclosure requirement of the preceding sentence shall not
apply to Work Product (a) for which no equipment, supplies, facilities, or trade
secrets information of the Company was used, (b) which was developed entirely on
my own time, (c) which does not relate to the business of the Company or to the
Company's actual or demonstrably anticipated research or development, and (d)
which does not result from any work performed by me for the Company. Thus, the
only Work Product not required to be disclosed to the Company is Work Product
satisfying all four conditions (a), (b), (c), and (d) above; such Work Product
not required to be disclosed to the Company is hereinafter referred to as
"Personal Work Product". I agree that if I am in doubt as to whether any given
Work Product must be disclosed to the Company by the terms of this Agreement, I
will refer such question to the management of the Company.

     B.   Assignment to Company of Inventions

     I agree that all Work Product other than Personal Work Product shall
forthwith and without further consideration become, and hereby without further
action, is the exclusive property of the Company, its successors, and assigns. I
hereby assign to the Company all patents, copyrights, mask works or other
statutory or common law protections in any and all countries for the Work
Product required to be disclosed under this Agreement, except Personal Work
Product. [Notice is hereby given hat the foregoing inventions assignable to the
Company do not include any invention which qualifies fully for exemption under
Section 2870 of the California Labor Code.] I hereby appoint the Company's
Secretary or any other officer of the Company as my attorney-in-fact and agent
to execute all documents required or appropriate to perfect or enforce all
rights assigned under this Agreement.

     I will assist the Company in every proper way, including the signing of any
and all papers, authorizations, applications, and assignments, the making and
keeping of proper records, and the giving of evidence and testimony (all
entirely at the Company's expense), to obtain and to maintain for the use and
benefit of the Company or its moninees patents, copyrights, mask works or other
form of protection, in all countries, for any and all Work Product other than
Personal Work Product. My obligations under this Section IIB will extend beyond
the termination of my employment with the Company.

     As a matter of record, I have filled out, and have been given sufficient
time to fill out, the following Schedule A which contains a complete list of all
ideas, inventions, works, improvements, and discoveries, patented and
unpatented, copyrighted and not copyrighted, which I completed prior to my
employment and which I desire to have specifically excluded from the operation
of Sections IIA and IIB of this Agreement.

III. Non-disclosure and Retention of Certain Company Information

     A.   Non-disclosure of Company Confidential Information

     I will regard and preserve as confidential and will not divulge to
"unauthorized persons" as defined below, or use or authorize or encourage
persons who are under my direction or supervision to use for any unauthorized
purposes, either during or after the term of my employment, any information,
matter, or thing of secret, confidential, or private nature connected with the
business of the Company or any of its

                                       3
<PAGE>

suppliers, customers or their affiliates without the written consent of the
President of the Company until such time as such information otherwise becomes
public knowledge or is disclosed to me without restriction as a matter of right
by a third party not affiliated with or working for the Company. Included within
the meaning of the foregoing are matters of a technical nature, such as
know-how, formulae, computer programs, software, logic design, and
documentation, secret processes or machines, inventions and research projects;
matters of a business nature, such as information about costs, profits, markets,
sales, customers, suppliers, and employees (including salary, evaluation, and
other personnel data); plans for further development; and any other information
of a similar nature. In these regards, although certain information or
technology may be generally known in the relevant industry, the fact that the
Company uses same, and how the Company uses same, may not be so known and
therefore is subject to non=disclosure and non-use. Furthermore, the fact that
various fragments of information or data may be generally known in the relevant
industry does not mean that the manner in which the Company combines them and
the results obtained thereby are so known and in such instance are also subject
to non-disclosure and non-use. An "unauthorized person" is (i) any person with
such a need but who is not obligated both to similarly maintain such information
in confidence and use such information only for a Company-authorized purpose.

     Excluded from the restrictions of this Section IIIA is information known to
me prior to its disclosure to me by the Company. I agree that before making any
disclosure or use of confidential information not previously approved in writing
by the President of the Company in reliance upon the foregoing exclusion or the
fact that the information is public knowledge (other than through the Company's
own public disclosure) or has been disclosed to me without restriction as a
matter or right by a third party, I will give the Company at least ten (10)
business days prior written notice specifying the applicable reason and the
circumstances giving rise thereto. I shall have the burden of proving by clear
and convincing evidence that the given reason applies to such information under
such circumstances.

     B.   Retention of Company Data and Records

     I understand and agree that all data and records coming into my possession
or kept by me in connection with my employment, including, without limitation,
notebooks, drawings and blueprints; computer programs, software, logic design,
and documentation; bulletins, parts lists, reports, and customer lists;
production, cost, purchasing, and marketing information; and employment data,
including policies and salary information, are the exclusive property of the
Company. I agree to return to the Company all originals and copies of such data
and records upon termination of my employment for any reason, unless specific
written consent is obtained from the President of the Company to retain any such
data or records.

IV.  Non-solicitation of Employees:

     During my employment with the Company and for a period of one year after
the termination of my employment with the Company for any reason, in order to
enable the Company to maintain a stable work force and to operate its business,
I agree that I will not solicit or encourage (nor will I direct or encourage
anyone under my authority or control to solicit or encourage) any of the
Company's employees to work elsewhere.

                                       4
<PAGE>

V.   At -Will Employment and Arbitration

     A.   At Will Employment

     I am free to terminate my employment with the Company at any time, with or
without a reason, and the Company has the right to terminate my employment at
any time, with or without reason. Although the Company may choose to terminate
my employment for cause, cause is not required. This is called "at-will"
employment. The policy of at-will employment may be changed only in writing
signed by the President. This Agreement shall not be altered or terminated by
changes in duties, compensation or other circumstances of my employment.

     B.   Arbitration

     Any legal dispute between me and the Company arising out of my employment
or termination of employment or this agreement shall be settled by binding
arbitration in Orange County, California, before the Judicial Arbitration and
Mediation Services, Inc. (JAMS), following the JAMS Rules of Practice and
Procedure. This includes, but is not limited to, any and all claims arising out
of my employment with the Company or the termination of that employment. This
includes any claims I may make relating to alleged discrimination or harassment
during my employment based on race, color, national origin, religion,
disability, age, gender or sexual orientation, any claims relating to
compensation (wages, bonuses, commissions, benefits, etc.) and any claims under
federal, state or local laws or regulations relating to terms and conditions of
employment. This also includes any claims for wrongful discharge, fraud,
misrepresentation, intentional or negligent infliction of emotional distress and
any claims that the Company has dealt with me unfairly or in bad faith. I
UNDERSTAND THAT BY AGREEING TO ARBITRATE SUCH DISPUTES I AM WAIVING ANY RIGHT I
MIGHT OTHERWISE HAVE TO A JURY TRIAL. This arbitration provision is not intended
to modify or limit my substantive rights or the remedies available to me or to
the Company, including the right to seek interim relief, such as injunction or
attachment, through judicial process, which shall not be deemed a waiver of the
right to demand and obtain arbitration. A copy of the JAMS rules may be obtained
by calling JAMS at 1-800-352-JAMS.

/s/ MQ (Initial)

     C.   Miscellaneous

     I hereby authorize the Company to disclose this Agreement and my
responsibilities hereunder to any person or entity, including, without
limitation, my future employers or clients.

     This Agreement shall be governed by and construed in accordance with the
internal laws of the State of California for contracts entered into in
California between California residents. The invalidity or unenforceability of
any provision(s) of this Agreement under particular facts and circumstances
shall not affect the validity or enforceability either of other provisions of
this Agreement or, under other facts and circumstances, of such provision(s). In
addition, such provision(s) shall be reformed to be less restrictive if under
such facts and circumstances they would then be valid and enforceable. The
headings in this Agreement are solely for convenience and shall not be
considered in its interpretation. This Agreement shall be binding upon my heirs,
executors, administrators, and personal representatives and shall inure to the
benefit of the Company and its successors or assigns.

                                       5
<PAGE>

                    CONFIDENTIALITY AND INTELLECTUAL PROPERTY
                                    AGREEMENT

     This Agreement constitutes my entire agreement and understanding with the
Company concerning its subject matter. It merges with and supercedes the
provisions of all previous agreements and understandings, whether written, oral,
or implied, that I have made with the Company. This Agreement may be amended or
waived only In writing signed by myself and the President of the Company. I
UNDERSTAND THAT THIS AGREEMENT IS EFFECTIVE AS OF THE DATE MY EMPLOYMENT WITH
THE COMPANY COMMENCED OR WILL COMMENCE

                                    Employee

                                            /s/ MICHAEL QUINN
Date: 10/30/05                              ------------------------------------
                                            Signature

                                            MICHAEL QUINN
                                            ------------------------------------
                                            Printed Name

WITNESSED BY:

--------------------------

Accepted this 31st day, October, 2005

CardioGenesis, Corp.

By: /s/ ED MUSOLFF
    --------------------------

    ED MUSOLFF
    --------------------------
    Printed Name and Title

                                       6
<PAGE>

                              [CARDIOGENESIS LOGO]

                                  CARDIOGENESIS
                        Receipt of the Employee Handbook

This Employee Handbook is intended to set forth, for the benefit of its
employees, primary provisions of the benefit plans and the policies, procedures,
rules and regulations of Cardiogenesis. The Employee Handbook is located on the
Public Folders under Human Resources/Policies and Procedures and is available
for review at any time to all employees.

The Company expects to periodically review all of the provisions and contents of
this Employee handbook. The Company reserves the right to change any stated
policies, procedures, or other terms, upon advance notice to employees, either
by issuance of a supplementary sheet to this Employee Handbook, or by posting of
such change on the Public Folders.

The undersigned employee hereby acknowledges and agrees to the following:

-    That my employment with Cardiogenesis is at-will, and therefore, my
     employment and compensation can terminate, with or without cause, and with
     or without notice, at any time, at my option or the Company's option.

-    That this at-will employment relationship will remain in effect throughout
     my employment with the Company, or any of its parent or affiliated
     companies, unless it is modified by a specific, express written employment
     contract executed by me and by a senior officer of the Company on its
     behalf.

-    That I have read the Employee Handbook, understand its contents, and agree
     to conform to all of the policies, procedures, rules and regulations of the
     Company described in the Employee Handbook and if I have any questions
     regarding the content or interpretation of the Handbook, I will discuss
     them with my immediate manager or Human Resources.

/s/ MICHAEL QUINN
-----------------
Employee Signature                                      Date 10/30/05

MICHAEL QUINN
----------------
Print Name

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}]]